Oncotarget

Vol 5, No 19

October 15, 2014

View Archive »

Order a Reprint

About The Cover

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential. See Raffeiner et al.

Table of Contents

Editorial

New targets for resistant prostate cancer

New targets for resistant prostate cancer

https://doi.org/10.18632/oncotarget.2544

Timothy C. Thompson,  and Likun Li
8816-8817
PDF  |  Order a Reprint

Reviews

Axl as a mediator of cellular growth and survival

Axl as a mediator of cellular growth and survival

https://doi.org/10.18632/oncotarget.2422

Haley Axelrod,  and Kenneth J. Pienta
8818-8852
Abstract  |  PDF  |  HTML  |  Order a Reprint

Priority Research Papers

Hypoxia-inducible factors enhance glutamate signaling in cancer cells

Hypoxia-inducible factors enhance glutamate signaling in cancer cells

https://doi.org/10.18632/oncotarget.2593

Hongxia Hu, Naoharu Takano, Lisha Xiang, Daniele M. Gilkes, Weibo Luo,  and Gregg L. Semenza
8853-8868
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential

https://doi.org/10.18632/oncotarget.2588

Philipp Raffeiner, Ruth Röck, Andrea Schraffl, Markus Hartl, Jonathan R. Hart, Kim D. Janda, Peter K. Vogt, Eduard Stefan,  and Klaus Bister
8869-8878
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism

Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism

https://doi.org/10.18632/oncotarget.2432

Xin Yu, Adam R. Blanden, Sumana Narayanan, Lalithapriya Jayakumar, David Lubin, David Augeri, S. David Kimball, Stewart N. Loh,  and Darren R. Carpizo
8879-8892
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells

MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells

https://doi.org/10.18632/oncotarget.2360

Akriti Kharbanda, Hasan Rajabi, Caining Jin, Maroof Alam, Kwok-Kin Wong,  and Donald Kufe
8893-8905
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The head and neck cancer cell oncogenome: A platform for the development of precision molecular therapies

The head and neck cancer cell oncogenome: A platform for the development of precision molecular therapies

https://doi.org/10.18632/oncotarget.2417

Daniel Martin, Martin C. Abba, Alfredo A. Molinolo, Lynn Vitale-Cross, Zhiyong Wang, Moraima Zaida, Naomi C. Delic, Yardena Samuels, Guy J. Lyons,  and J. Silvio Gutkind
8906-8923
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells

Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells

https://doi.org/10.18632/oncotarget.2441

Lan Yi, Yvonne Sun,  and Arnold Levine
8924-8936
Abstract  |  PDF  |  HTML  |  Order a Reprint

Clinical Research Papers

Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials

Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials

https://doi.org/10.18632/oncotarget.2339

Rabih Said, Yang Ye, Gerald Steven Falchook, Filip Janku, Aung Naing, Ralph Zinner, George R. Blumenschein Jr, Siqing Fu, David S. Hong, Sarina Anne Piha-Paul, Jennifer J. Wheler, Razelle Kurzrock, Gary A. Palmer, Kenneth Aldape, Kenneth . R Hess,  and Apostolia Maria Tsimberidou
8937-8946
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition

Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition

https://doi.org/10.18632/oncotarget.2407

Edward Allan R. Sison, Daniel Magoon, Li Li, Colleen E. Annesley, Donald Small,  and Patrick Brown
8947-8958
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Research Papers

The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells

The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells

https://doi.org/10.18632/oncotarget.1863

Joseph Mazar, Wei Zhao, Ahmad M. Khalil, Bongyong Lee, John Shelley, Subramaniam S. Govindarajan, Fumiko Yamamoto, Maya Ratnam, Muhammad Nauman Aftab, Sheila Collins, Brian N. Finck, Xianlin Han, John S. Mattick, Marcel E. Dinger,  and Ranjan J. Perera
8959-8969
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A novel tumor suppressor function of Kindlin-3 in solid cancer

A novel tumor suppressor function of Kindlin-3 in solid cancer

https://doi.org/10.18632/oncotarget.2125

Ibtissem Djaafri, Farah Khayati, Suzanne Menashi, Jorg Tost, Marie-Pierre Podgorniak, Aurelie Sadoux, Antoine Daunay, Luis Teixeira, Jean Soulier, Ahmed Idbaih, Niclas Setterblad, Françoise Fauvel, Fabien Calvo, Anne Janin, Celeste Lebbé,  and Samia Mourah
8970-8985
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth

Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth

https://doi.org/10.18632/oncotarget.1510

Jan Kroon, Lars S. in 't Veld, Jeroen T. Buijs, Henry Cheung, Geertje van der Horst,  and Gabri van der Pluijm
8986-8994
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model

The class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model

https://doi.org/10.18632/oncotarget.2297

Rada Amin, Abdelghafour Marfak, Céline Pangault, Christelle Oblet, Aurélie Chanut, Karin Tarte, Yves Denizot,  and Michel Cogné
8995-9006
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells

A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells

https://doi.org/10.18632/oncotarget.2346

Cale D. Fahrenholtz, Ann M. Greene, Pedro J. Beltran,  and Kerry L. Burnstein
9007-9021
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways

Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways

https://doi.org/10.18632/oncotarget.2493

Ksenia Lezhnina, Olga Kovalchuk, Alexander A. Zhavoronkov, Mikhail B. Korzinkin, Anastasia A. Zabolotneva, Peter V. Shegay, Dmitry G. Sokov, Nurshat M. Gaifullin, Igor G. Rusakov, Alexander M. Aliper, Sergey A. Roumiantsev, Boris Y. Alekseev, Nikolay M. Borisov,  and Anton A. Buzdin
9022-9032
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors

The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors

https://doi.org/10.18632/oncotarget.1925

Tun Kiat Ko, Charles T.H. Chuah, John W.J. Huang, King-Pan Ng,  and S. Tiong Ong
9033-9038
Abstract  |  PDF  |  HTML  |  Order a Reprint

Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme

Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme

https://doi.org/10.18632/oncotarget.1996

Xiaohui Yu, Lifang Yang, Murray J. Cairns, Crispin Dass, Edward Saravolac, Xiong Li,  and Lun-Quan Sun
9039-9048
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer

Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer

https://doi.org/10.18632/oncotarget.2022

Shuying Liu, Xiaolong Meng, Huiqin Chen, Wenbin Liu, Todd Miller, Mandi Murph Yiling Lu, Fan Zhang, Mihai Gagea, Carlos L. Arteaga, Gordon B. Mills, Funda Meric-Bernstam,  and Ana M. González-Angulo
9049-9064
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma

Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma

https://doi.org/10.18632/oncotarget.2375

Ju-Ae Hwang, Heung-Mo Yang, Doo-Pyo Hong, Sung-Yeon Joo, Yoon-La Choi, Joo-Hung Park, Alexander J. Lazar, Raphael E. Pollock, Dina Lev,  and Sung Joo Kim
9065-9078
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5

Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5

https://doi.org/10.18632/oncotarget.2376

Raghuveer Kavarthapu, Chon-Hwa Tsai Morris,  and Maria L. Dufau
9079-9091
Abstract  |  PDF  |  HTML  |  Order a Reprint

LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway

LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway

https://doi.org/10.18632/oncotarget.2377

Qing Chen, Hao-Zhe Cao,  and Peng-Sheng Zheng
9092-9105
Abstract  |  PDF  |  HTML  |  Order a Reprint

MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling

MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling

https://doi.org/10.18632/oncotarget.2379

Cen Zhang, Juan Liu, Xiaolong Wang, Rui Wu, Meihua Lin, Saurabh V. Laddha, Qifeng Yang, Chang S. Chan,  and Zhaohui Feng
9106-9117
Abstract  |  PDF  |  HTML  |  Order a Reprint

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

https://doi.org/10.18632/oncotarget.2361

Xin Chen, Xianping Shi, Chong Zhao, Xiaofen Li, Xiaoying Lan, Shouting Liu, Hongbiao Huang, Ningning Liu, Siyan Liao, Dan Zang, Wenbin Song, Quentin Liu, Bing Z. Carter, Ping Q. Dou, Xuejun Wang,  and Jinbao Liu
9118-9132
Abstract  |  PDF  |  HTML  |  Order a Reprint

p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation

p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation

https://doi.org/10.18632/oncotarget.2362

Carman Ka Man Ip, Susan Yung, Tak-Mao Chan, Sai-Wah Tsao,  and Alice Sze Tsai Wong
9133-9149
Abstract  |  PDF  |  HTML  |  Order a Reprint

Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer

Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer

https://doi.org/10.18632/oncotarget.2363

Hong Hua Yan, Kyung Hee Jung, Mi Kwon Son, Zhenghuan Fang, Soo Jung Kim, Ye-Lim Ryu, Juyoung Kim, Mi-Hyun Kim,  and Soon-Sun Hong
9150-9168
Abstract  |  PDF  |  HTML  |  Order a Reprint

Biphasic regulation of autophagy by miR-96 in prostate cancer cells under hypoxia

Biphasic regulation of autophagy by miR-96 in prostate cancer cells under hypoxia

https://doi.org/10.18632/oncotarget.2396

Yi Ma, Hao-Zheng Yang, Bai-Jun Dong, Han-Bing Zou, Yan Zhou, Xian-Ming Kong,  and Yi-Ran Huang
9169-9182
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia

Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia

https://doi.org/10.18632/oncotarget.2399

Shachar Raz, Michal Stark,  and Yehuda G. Assaraf
9183-9198
Abstract  |  PDF  |  HTML  |  Order a Reprint

Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy.

Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy.

https://doi.org/10.18632/oncotarget.2374

Elisa Donnard, Paula F. Asprino, Bruna R. Correa, Fabiana Bettoni, Fernanda Koyama, Fabio C. Navarro, Rodrigo O. Perez, John Mariadason, Oliver M. Sieber, Robert L. Straussberg, Andrew J.G. Simpson, Denis L.F. Jardim, Luiz Fernando L. Reis, Raphael B. Parmigiani, Pedro A.F. Galante,  and Anamaria A. Camargo
9199-9213
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion

Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion

https://doi.org/10.18632/oncotarget.2400

Shulamit Sebban, Marganit Farago, Shiran Rabinovich, Galit Lazer, Yulia Idelchuck, Lena Ilan, Eli Pikarsky,  and Shulamit Katzav
9214-9226
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer

Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer

https://doi.org/10.18632/oncotarget.2402

Jong-Lyel Roh, Eun Hye Kim, Jin Young Park, Ji Won Kim, Minsu Kwon,  and Byung-Heon Lee
9227-9238
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab

Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab

https://doi.org/10.18632/oncotarget.2409

Rita De Santis, Antonio Rosi, Anna Maria Anastasi, Caterina Chiapparino, Claudio Albertoni, Barbara Leoni, Angela Pelliccia, Daniela Santapaola, Valeria Carollo, Emanuele Marra, Luigi Aurisicchio, Brunilde Arseni, Maria Lucrezia Pacello, Gabriella Palmieri, Simone Battella, Fiorella Petronzelli,  and Ferdinando Maria Milazzo
9239-9255
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Rpb3 promotes hepatocellular carcinoma through its N-terminus

Rpb3 promotes hepatocellular carcinoma through its N-terminus

https://doi.org/10.18632/oncotarget.2389

Zhe-Ping Fang, Bei-Ge Jiang, Fa-Biao Zhang, Ai-Dong Wang, Yi-Ming Ji, Ji-Cheng Li, Wei-Ping Zhou, Hai-Xiong Han,  and Wei-Jie Zhou
9256-9268
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition

DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition

https://doi.org/10.18632/oncotarget.2393

Parthasarathy Chandrakesan, Nathaniel Weygant, Randal May, Dongfeng Qu, Harisha R. Chinthalapally, Sripathi M. Sureban, Naushad Ali, Stan A. Lightfoot, Shahid Umar,  and Courtney W. Houchen
9269-9280
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC

Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC

https://doi.org/10.18632/oncotarget.2423

Kaihua Zhang, Lamont Jones, Sora Lim, Christopher A. Maher, Douglas Adkins, James Lewis, Randall J. Kimple, Elana J. Fertig, Christine H. Chung, Andreas Herrlich, Matthew J. Ellis, Brian A. Van Tine,  and Loren S. Michel
9281-9294
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features

Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features

https://doi.org/10.18632/oncotarget.2424

Elina Jokinen, Niina Laurila, Peppi Koivunen,  and Jussi P. Koivunen
9295-9307
Abstract  |  PDF  |  HTML  |  Order a Reprint

Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia

Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia

https://doi.org/10.18632/oncotarget.2425

Sabrina Copsel, Ariana Bruzzone, Maria May, Julien Beyrath, Victoria Wargon, Jeannette Cany, Frans G.M. Russel, Carina Shayo,  and Carlos Davio
9308-9321
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment

P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment

https://doi.org/10.18632/oncotarget.2427

Young Nak Joo, Hana Jin, So Young Eun, Sang Won Park, Ki Churl Chang,  and Hye Jung Kim
9322-9334
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway

Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway

https://doi.org/10.18632/oncotarget.2429

Andressa Ardiani, Sofia R. Gameiro, Anna R. Kwilas, Renee N. Donahue,  and James W. Hodge
9335-9348
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers

Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers

https://doi.org/10.18632/oncotarget.2430

Wei Guo, Jianjun Lu, Meng Dai, Taihua Wu, Zhenlong Yu, Jingshu Wang, Wangbing Chen, Dingbo Shi, Wendan Yu, Yao Xiao, Canhui Yi, Zhipeng Tang, Tingting Xu, Xiangsheng Xiao, Yuhui Yuan, Quentin Liu, Guangwei Du,  and Wuguo Deng
9349-9361
Abstract  |  PDF  |  HTML  |  Order a Reprint

The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer

The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer

https://doi.org/10.18632/oncotarget.2433

Martin C. Sadowski, Rebecca H. Pouwer, Jennifer H. Gunter, Amy A. Lubik, Ronald J. Quinn,  and Colleen C. Nelson
9362-9381
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Transcriptional profiling of GBM invasion genes identifies effective inhibitors of the LIM kinase-Cofilin pathway

Transcriptional profiling of GBM invasion genes identifies effective inhibitors of the LIM kinase-Cofilin pathway

https://doi.org/10.18632/oncotarget.2412

Jun-Bum Park, Sameer Agnihotri, Brian Golbourn, Kelsey C. Bertrand, Amanda Luck, Nesrin Sabha, Christian A. Smith, Sara Byron, Gelareh Zadeh, Sidney Croul, Michael Berens,  and James T. Rutka
9382-9395
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The DNA2 nuclease/helicase is an estrogen-dependent gene mutated in breast and ovarian cancers

The DNA2 nuclease/helicase is an estrogen-dependent gene mutated in breast and ovarian cancers

https://doi.org/10.18632/oncotarget.2414

Carmit Strauss, Maya Kornowski, Avraham Benvenisty, Amit Shahar, Hadas Masury, Ittai Ben-Porath, Tommer Ravid, Ayelet Arbel-Eden,  and Michal Goldberg
9396-9409
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Overexpression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer

Overexpression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer

https://doi.org/10.18632/oncotarget.2421

Zunfu Ke, Weiling He, Yuanhui Lai, Xuefeng Guo, Sharon Chen, Shuhua Li, Yuefeng Wang,  and Liantang Wang
9410-9424
Abstract  |  PDF  |  HTML  |  Order a Reprint

Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis

Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis

https://doi.org/10.18632/oncotarget.2444

Ryan A. Hlady, Rochelle L. Tiedemann, William Puszyk, Ivan Zendejas, Lewis R. Roberts, Jeong-Hyeon Choi, Chen Liu,  and Keith D. Robertson
9425-9443
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2

miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2

https://doi.org/10.18632/oncotarget.2452

Szu-Mam Liu, Jean Lu, Hoong-Chien Lee, Feng-Hsiang Chung,  and Nianhan Ma
9444-9459
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer

https://doi.org/10.18632/oncotarget.2455

Glen P. Marszalowicz, Adam E. Snook, Michael S. Magee, Dante Merlino, Lisa D. Berman-Booty,  and Scott A. Waldman
9460-9471
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma

miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma

https://doi.org/10.18632/oncotarget.2418

Meng Xu, Hua Jin, Cheng-Xiong Xu, Bo Sun, Zhi Mao, Wen-Zhi Bi,  and Yan Wang
9472-9483
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

What makes a blood cell based miRNA expression pattern disease specific? - A miRNome analysis of blood cell subsets in lung cancer patients and healthy controls

What makes a blood cell based miRNA expression pattern disease specific? - A miRNome analysis of blood cell subsets in lung cancer patients and healthy controls

https://doi.org/10.18632/oncotarget.2419

Petra Leidinger, Christina Backes, Indra N. Dahmke, Valentina Galata, Hanno Huwer, Ingo Stehle, Robert Bals, Andreas Keller,  and Eckart Meese
9484-9497
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer

TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer

https://doi.org/10.18632/oncotarget.2411

Xuefeng Li, Yunying Liu, Wenqi Chen, Yuxiang Fang, Huiming Xu, HelenHe Zhu, Mingliang Chu, Wang Li, Guanglei Zhuang,  and Wei-Qiang Gao
9498-9513
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells

FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells

https://doi.org/10.18632/oncotarget.2413

Hong-Jian Wei, Wen-Cheng Lo, Jac A. Nickoloff, Wei-Hong Chen, Hen-Yu Liu, Ya-Ting Chang, Pan-Chyr Yang, Cheng-Wen Wu, David F. Williams, Juri G. Gelovani,  and Win-Ping Deng
9514-9529
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint


Copyright © 2017 Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC